The company has substantially boosted its progress of an novel therapy for cardiac amyloidosis, employing the compound. Preliminary clinical data suggests significant improvements for those suffering with the severe https://attr-cm820386.blogolenta.com/39199944/bridgebio-advances-cardiac-amyloidosis-treatment-using-the-drug